Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,885 across all filing types
Latest filing 2024-04-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 九芝堂股份有限公司 regarding abnormal stock price fluctuations and related internal control issues. It includes explanations about the stock price drop, company self-inspection results, risk warnings, and references to previous announcements about accounting errors and internal control audit reports. The document does not contain financial statements or detailed financial data but serves as a regulatory disclosure about stock trading abnormalities and internal control audit opinions. It is not an annual report, interim report, earnings release, or any detailed financial report. It is also not a certification letter or a proxy statement. Given the nature of the content—disclosure of stock price abnormality, internal control audit opinion, and risk warnings—this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-29 Chinese
关于公司及相关人员收到行政监管措施决定书的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding administrative regulatory measures taken against the company and certain executives by the China Securities Regulatory Commission (CSRC) Hunan Bureau. It details violations found, penalties imposed, and the company's response. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about legal and compliance issues, not a financial report or management discussion. It fits the category of Legal Proceedings Report (LTR) as it updates on significant regulatory actions involving the company.
2024-04-29 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is titled as an announcement regarding the company's first share repurchase. It details the board meeting approval of the share buyback plan, the specifics of the first repurchase transaction including number of shares, price, and compliance with regulatory rules. The document is an announcement of a share repurchase event, not a full financial report or earnings release. It fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length is short and focused solely on the repurchase event, confirming it is not a full report or regulatory filing of another type.
2024-04-28 Chinese
关于前期会计差错更正后的财务报表及相关附注
Annual Report Classification · 95% confidence The document is a detailed financial report from 九芝堂股份有限公司 regarding the correction of prior accounting errors and the restated financial statements for the fiscal year 2022. It includes comprehensive financial data such as the consolidated balance sheet, income statement, notes on financial statement items, and detailed disclosures about accounting policies and adjustments. The presence of full financial statements and extensive notes indicates this is a formal financial report rather than a brief announcement or certification. The document is not a quarterly or interim report since it covers the full year 2022 and includes restated annual financials. Therefore, it fits the definition of an Annual Report (10-K) type filing, as it covers the company's full financial performance for the year with detailed financial statements and disclosures. FY 2022
2024-04-25 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as a 2023 annual report summary for 九芝堂股份有限公司, containing detailed financial data for the year 2023, including main accounting data, financial indicators, quarterly data, shareholder information, and business overview. It references the full annual report and includes comprehensive financial figures and analysis, not just an announcement or a brief summary. The length is over 13,000 characters, indicating a substantive report rather than a short announcement. The content matches the characteristics of an Annual Report (10-K) as it covers company activity and full financial performance for the fiscal year 2023. FY 2023
2024-04-24 Chinese
2023年度监事会报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2023年度监事会报告" which translates to "2023 Supervisory Board Report". It contains detailed supervisory board activities, including meetings held, oversight of financial conditions, audit opinions, asset transactions, related party transactions, information disclosure, and internal control evaluation for the fiscal year 2023. The document includes references to an audit report issued by an accounting firm but does not itself contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is a formal report from the supervisory board summarizing their oversight and findings for the year, which aligns with the category of Audit Report / Information (AR). The document length is 1587 characters, which is short but contains substantive supervisory content rather than just an announcement or certification. Therefore, the best fit is AR. FY 2023
2024-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.